Options trading volumes have surged in recent years, and zero-days-to-expiration (0DTE) options have emerged as a popular ...
Piper Sandler launched the coverage of a raft of cancer-focused biotechs with bullish views on Monday while issuing a Neutral recommendation on Summit Therapeutics (NASDAQ:SMMT), citing an unfavorable ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback